The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
